Both drugs can cost around $1,000 a month or more without insurance coverage.
Though not formally approved for obesity, Ozempic has become increasingly prescribed off-label for it.
The years since Wegovys approval have solidified its effectiveness as a treatment forweight loss and beyond.
Senator Bernie Sanders at a rally in Boston on February 29, 2020.Image: Lauryn Allen (Shutterstock)
In November 2023, Eli Lillys tirzepatide was approved for treating obesity.
Impressive as these drugs have been, though, they havent come cheap, at least in the U.S. And in many other countries, the out-of-pocket costs are substantially lower.
And there havealready been reportsof people getting hurt as a result.
News from the future, delivered to your present.